Early biochemical muscle injury and one-year clinical and imaging outcomes following microsurgical versus endoscopic lumbar discectomy: A prospective comparative study

显微外科与内镜腰椎间盘切除术后早期生化肌肉损伤及一年临床和影像学结果:一项前瞻性比较研究

阅读:2

Abstract

Background and objectives Minimally invasive spinal techniques aim to reduce tissue trauma while maintaining surgical efficacy. Comparative evidence integrating early biochemical muscle injury markers with long-term clinical and imaging outcomes remains limited. This study evaluated postoperative day 3 biochemical responses, and one-year clinical and MRI-based imaging changes between microsurgical lumbar discectomy (MLD) and percutaneous endoscopic lumbar discectomy (PELD). Methods 192 patients with single-level lumbar disc herniation (L4-L5 or L5-S1) underwent MLD (n=97) or PELD (n=95) between January 2022 and October 2024. Pain and disability were assessed using the visual analogue scale (VAS) and oswestry disability index (ODI) preoperatively and at one year. Serum creatine phosphokinase (CPK), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were measured preoperatively and on postoperative days (POD) 1 and 3. MRI was performed preoperatively and at one year to assess paraspinal muscle cross-sectional area (CSA), fatty infiltration (Goutallier grading), and disc height index. Results Both groups showed significant improvement in VAS and ODI at one year (P<0.05). PELD demonstrated lower POD 1 and 3 CPK, IL-6, and hs-CRP levels (P<0.05), and shorter operative duration (66.3±12 vs. 86±14 min). MRI followup revealed better preservation of muscle CSA and less fatty infiltration in PELD (P<0.05), with comparable disc height maintenance. Interpretation and conclusions While both MLD and PELD achieved similar one-year functional outcomes, PELD demonstrated lower early biochemical markers and superior radiological muscle preservation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。